Pinnaclife Is Excited to Continue Its Partnership With Leading Dermatological Veterinarians

CORALVILLE, Iowa, Sept. 4, 2012 /PRNewswire/ -- Pinnaclife, Inc., an Iowa-based science company, is excited to continue its partnership with leading dermatological veterinarians Craig Griffin, DVM, Diplomate ACVD and Wayne Rosenkrantz DVM, Diplomate ACVD on its Animal Health Product Line. Dr. Griffin and Dr. Rosenkrantz oversaw initial case studies of Pinnaclife Animal Health Products, and collaborated with the product's inventor Darlene McCord, PhD, FAPWCA, CSO of McCord Research, Pinnaclife's parent company. "We are very excited about the opportunity to work with this company and evaluate the products further in more controlled studies, but the initial preliminary case studies as well as the in vitro results are very promising and we are looking forward to the future of a highly successful product line," said Dr. Rosenkrantz when asked about the Pinnaclife Animal Health Line. 

(Logo: http://photos.prnewswire.com/prnh/20111107/CG00376LOGO)

The veterinarians will continue their partnership with Pinnaclife by conducting future controlled trials on Pinnaclife Animal Health Products as well as writing a newsletter about veterinary dermatology and collaborating on other Pinnaclife veterinary educational materials and product development. Pinnaclife was honored with a visit from Dr. Griffin at last weekend's CVC conference in Kansas City, Missouri.

About Pinnaclife Animal Health
Pinnaclife Animal Health Line is formulated by Dr. Darlene McCord, inventor of the current #1 selling medical human skin care line in North America, with collaboration and testing support from leading veterinary dermatologists Dr. Griffin and Dr. Rosenkrantz. This short line, available only through prescribing veterinarians, boasts products with specific uses, and also features two deterrent products for cases that require a deterrent for licking and chewing.  Visit www.pinnaclifeanimalhealth.com to learn more.

FOR MORE INFORMATION:
Pinnaclife, Inc.
(319) 351-3201
[email protected]
www.pinnaclifeanimalhealth.com
www.pinnaclife.com 

SOURCE Pinnaclife, Inc.

Suggested Articles

Out of options, Tocagen will become Forte Biosciences’ route to the public markets through an all-stock reverse merger.

Reich co-founded Effector and served as its SVP of research but has moved on to take up the CSO position at Turning Point Therapeutics.

BioMarin’s hemophilia A drug has been set an Aug. 21 PDUFA date as the California biotech looks to gain a speedy approval.